ESR1 gene and insulin resistance remission are associated with serum uric acid decline for severely obese patients undergoing bariatric surgery
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 10 (1) , 14-22
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Dietary assessment of adolescents undergoing laparoscopic Roux-en-Y gastric bypass surgery: macro- and micronutrient, fiber, and supplement intakeSurgery for Obesity and Related Diseases, 2012
- A Genome-Wide Association Study Reveals a Quantitative Trait Locus of Adiponectin on CDH13 That Predicts Cardiometabolic OutcomesDiabetes, 2011
- Effect of Serum Insulin on the Association Between Hyperuricemia and Incident Heart FailureThe American Journal of Cardiology, 2010
- Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypassInternational Journal of Obesity, 2009
- Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of AtherosclerosisMetabolism, 2009
- Serum uric acid level as an independent risk factor for all‐cause, cardiovascular, and ischemic stroke mortality: A chinese cohort studyArthritis Care & Research, 2009
- Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesityBMC Research Notes, 2009
- Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in KoreaJournal of Korean Medical Science, 2008
- Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicineArthritis Research & Therapy, 2008
- The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years onNature Protocols, 2006